Eric G. Mohler, PhD

psychopharmacology; biological psychiatry
"Eric Mohler"
Mean distance: 14.99 (cluster 19)


Sign in to add mentor
Christina Williams grad student 1996-2002 Duke
Paul E. Gold post-doc UIUC
Michael E. Ragozzino post-doc University of Illinois, Chicago
Ben Givens research scientist Ohio State
 (Undergraduate thesis advisor)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Lindner K, Beckenbauer K, van Ek LC, et al. (2022) Isoform- and cell-state-specific lipidation of ApoE in astrocytes. Cell Reports. 38: 110435
Krishnan N, Chen X, Donnelly-Roberts D, et al. (2020) Small Molecule Phenotypic Screen Identifies Novel Regulators of LDLR Expression. Acs Chemical Biology
Gardner RS, Newman LA, Mohler EG, et al. (2020) Aging is not equal across memory systems. Neurobiology of Learning and Memory. 172: 107232
Petros AM, Korepanova A, Jakob CG, et al. (2019) Fragment-based Discovery of an ApolipoproteinE4 (apoE4) Stabilizer. Journal of Medicinal Chemistry
Ding Z, Brown JW, Rueter LE, et al. (2018) Profiling attention and cognition enhancing drugs in a rat touchscreen-based continuous performance test. Psychopharmacology
Hudzik TJ, Basso AM, Lynch JJ, et al. (2017) Preclinical abuse liability assessment of ABT-126, an agonist at the α7 nicotinic acetylcholine receptor (nAChR). Pharmacology, Biochemistry, and Behavior
Mohler EG, Ding Z, Rueter LE, et al. (2015) Cross-site strain comparison of pharmacological deficits in the touchscreen visual discrimination test. Psychopharmacology
Mohler EG, Franklin SR, Rueter LE. (2014) Discriminative-stimulus effects of NS9283, a nicotinic α4β2* positive allosteric modulator, in nicotine-discriminating rats. Psychopharmacology. 231: 67-74
Mohler EG, Baker PM, Gannon KS, et al. (2012) The effects of PRX-07034, a novel 5-HT6 antagonist, on cognitive flexibility and working memory in rats. Psychopharmacology. 220: 687-96
Lenz RA, Baker JD, Locke C, et al. (2012) The scopolamine model as a pharmacodynamic marker in early drug development. Psychopharmacology. 220: 97-107
See more...